Prospects in Eastern Europe

Thorsten Harke, president, Harke Group
Thorsten Harke, president, Harke Group

What kind of growth do you aspire to in the next few years; in which sectors, markets or regions do you see significant growth opportunities?

Despite the Ukrainian crisis, we see continued growth opportunities in Russia, Ukraine, as well as basically all other Eastern European markets. These opportunities relate to all different areas of chemical distribution with special focus on certain industries depending on the country. We also see further growth potential in Turkey and partly in the Middle East.

How do you intend to implement these plans and seize these opportunities?

We intend to participate in these growth opportunities through our subsidiaries and sales offices in these countries and regions, whereas we are currently serving the Middle East from our subsidiary in Turkey as bridgehead.

Company

Logo:

Harke Group GmbH

Xantener Str. 1
45479 Mülheim
Germany

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
19.03.2025 • TopicsStrategy

Substances of Concern

The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.